UniPharma Co., Ltd.

UniPharma Co., Ltd.verified

6621.TWO

Price:

$12.05

Market Cap:

$427.79M

UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. The company provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. It offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was incorporated in 1998 and is based in Taipei, Taiwan.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-08-18

Stock Exchange

TWO

Ticker

6621.TWO

The PE Ratio as of December 2025 (TTM) for UniPharma Co., Ltd. (6621.TWO) is -11.06

According to UniPharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -11.06. This represents a change of 24.20% compared to the average of -8.90 of the last 4 quarters.

UniPharma Co., Ltd. (6621.TWO) Historical PE Ratio (quarterly & annually)

How has 6621.TWO PE Ratio performed in the past?

The mean historical PE Ratio of UniPharma Co., Ltd. over the last ten years is -26.31. The current -11.06 PE Ratio has changed 4.10% with respect to the historical average. Over the past ten years (40 quarters), 6621.TWO's PE Ratio was at its highest in in the June 2022 quarter at 39.96. The PE Ratio was at its lowest in in the June 2023 quarter at -33.00.

Quarterly (TTM)
Annual

Average

-26.31

Median

-16.28

Minimum

-85.60

Maximum

-5.46

UniPharma Co., Ltd. (6621.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of UniPharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.47%

Maximum Annual PE Ratio = -5.46

Minimum Annual Increase = -71.66%

Minimum Annual PE Ratio = -85.60

Quarterly (TTM)
Annual
YearPE RatioChange
2024-19.81-18.35%
2023-24.26-71.66%
2022-85.601.47%
2021-5.46-45.27%
2020-9.98-21.72%

UniPharma Co., Ltd. (6621.TWO) Average PE Ratio

How has 6621.TWO PE Ratio performed in the past?

The current PE Ratio of UniPharma Co., Ltd. (6621.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-43.23

5-year avg

-29.02

10-year avg

-26.31

UniPharma Co., Ltd. (6621.TWO) PE Ratio vs. Peers

How is 6621.TWO’s PE Ratio compared to its peers?

UniPharma Co., Ltd.’s PE Ratio is greater than DuoGenic StemCells corporation (-13.48), greater than EPS Bio Technology Corp. (-28.64), less than Pharmigene, Inc. (-6.95), less than Welgene Biotech Co.,Ltd. (186.45), less than Taiwan Advanced Nanotech Inc. (-2.39), greater than Sunder Biomedical Tech. Co., Ltd. (-50.55), less than iXensor Co., Ltd. (-4.30), less than Bioray Biotech Co., Ltd (19.89), less than A-SPINE Asia Co., Ltd. (53.12), greater than Health & Life Co., Ltd. (-37.83),

Build a custom stock screener for UniPharma Co., Ltd. (6621.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UniPharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

UniPharma Co., Ltd. (6621.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like UniPharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is UniPharma Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for UniPharma Co., Ltd. (6621.TWO)?

What is the highest PE Ratio for UniPharma Co., Ltd. (6621.TWO)?

What is the 3-year average PE Ratio for UniPharma Co., Ltd. (6621.TWO)?

What is the 5-year average PE Ratio for UniPharma Co., Ltd. (6621.TWO)?

How does the current PE Ratio for UniPharma Co., Ltd. (6621.TWO) compare to its historical average?